Cancer du poumon: un petit pas?
openaire +1 more source
Programmed Death Ligand-1 Expression and Its Determinants in Patients with Lung Cancer: A Tertiary Care Center Experience in India. [PDF]
Arif M +7 more
europepmc +1 more source
Recherche critique axée sur la patientèle : un changement fondamental dans la participation des patients et des patientes. [PDF]
Sayani A, Maybee A.
europepmc +1 more source
Analyse en conditions réelles des effets indésirables des anticorps mobilisateurs de lymphocytes T administrés en oncologie et des conséquences opérationnelles. [PDF]
Fernandes S +4 more
europepmc +1 more source
Embolie pulmonaire à risque intermédiaire–élevé chez une femme de 53 ans présentant un cancer colorectal et une contre-indication à la thrombolyse. [PDF]
Hanson NL, Utgikar R, Bokhari M, Tan KT.
europepmc +1 more source
Rifampicin for the treatment of a cardiogenic shock related to mavacamten toxicity: the worse and the best of drug interactions from a case report. [PDF]
Lucas S +7 more
europepmc +1 more source
Screening Criteria Evaluation for Expansion in Pulmonary Neoplasias (SCREEN) II. [PDF]
Huo B +7 more
europepmc +1 more source
[Descriptive analytical study of patient survival with vertebral metastases in a rheumatological setting in Togo]. [PDF]
Oniankitan S +9 more
europepmc +1 more source
Endobronchial Actinomycosis - The Great Masquerader. [PDF]
Al Shuraiqi M +5 more
europepmc +1 more source
Is pneumonectomy still relevant for non-small cell lung cancer? Long-term overall survival from a 15-year experience. [PDF]
Hache PL +8 more
europepmc +1 more source

